Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
7%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
ARKG
35
HOLDINGS
25%
ALSO IN IDNA
IDNA
44
HOLDINGS
21%
ALSO IN ARKG
SECTOR DRIFT (ARKG minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
| TWIST BIOSCIENCE CORP. | 5.5% | 3.4% | 3.4% | |
| INCYTE CORP | 1.2% | 5.5% | 1.2% | |
| PACIFIC BIOSCIENCES OF CALIF | 1.6% | 0.9% | 0.9% | |
| REGENERON PHARMACEUTICALS | 0.7% | 4.8% | 0.7% | |
| ALCOBRA LTD | 1.8% | 0.4% | 0.4% | |
ARKG Overweight Relative to IDNA
| CRISPR THERAPEUTICS AG | 8.3% | |
| GUARDANT HEALTH, INC. | 5.9% | |
| NATERA INC | 4.7% | |
| PERSONALIS, INC. | 4.7% | |
| RECURSION PHARMACEUTICALS, INC CLASS | 4.5% | |
| 10X GENOMICS INC CLASS A | 4.3% | |
| ILLUMINA INC | 4.1% | |
| VERACYTE INC | 4.0% | |
| BEAM THERAPEUTICS, INC. | 3.8% | |
| ADAPTIVE BIOTECHNOLOGIES CORP. | 3.4% |
ARKG Underweight Relative to IDNA
| REVOLUTION MEDICINES, INC. | -5.3% | |
| CELCUITY INC. | -4.6% | |
| GENMAB A/S | -4.6% | |
| ARCELLX, INC. | -4.5% | |
| INCYTE CORP | -4.3% | |
| ASTRAZENECA PLC | -4.2% | |
| REGENERON PHARMACEUTICALS | -4.1% | |
| GSK PLC | -4.1% | |
| MERCK & CO. INC. | -3.9% | |
| ROCHE HOLDING LTD | -3.7% |